Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $33 - $40
3 New
3 $41,000
Q4 2023

Jun 26, 2024

SELL
$8.77 - $10.85 $26 - $32
-3 Closed
0 $5,000
Q4 2023

Feb 15, 2024

BUY
$8.77 - $10.85 $0 - $0
0 New
0 $0
Q3 2023

Nov 15, 2023

SELL
$9.59 - $11.35 $95 - $113
-10 Closed
0 $0
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $9 - $12
-1 Reduced 9.09%
10 $1.81 Million
Q4 2022

Feb 15, 2023

SELL
$8.72 - $11.56 $61 - $80
-7 Reduced 38.89%
11 $1.54 Million
Q3 2022

Nov 03, 2022

SELL
$8.48 - $11.13 $16 - $22
-2 Reduced 10.0%
18 $3,000
Q2 2022

Aug 05, 2022

SELL
$9.95 - $12.27 $19 - $24
-2 Reduced 9.09%
20 $5,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $58 - $92
-6 Reduced 21.43%
22 $5,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $338 - $411
28 New
28 $6,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $0 - $0
0 New
0 $14,000
Q2 2021

Aug 11, 2021

BUY
$12.97 - $16.15 $0 - $0
0 New
0 $14,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.